'For the quarter ending March 2024, Consolidated Net sales (including other operating income) of Alkem Laboratories has increased 1.14% to Rs 2935.82 crore compared to quarter ended March 2023. Operating profit margin has jumped from 12.17% to 13.69%, leading to 13.79% rise in operating profit to Rs 401.98 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 27.88% to 26.56%.   Purchase of finished goods cost rose from 12.54% to 12.66%.   Employee cost decreased from 18.20% to 16.82%.   Other expenses rose from 28.61% to 30.61%.   

Other income rose 28.40% to Rs 88.17 crore.  PBIDT rose 16.17% to Rs 490.15 crore.  Provision for interest fell 7.25% to Rs 26.86 crore.  Loan funds rose to Rs 1,540.14 crore as of 31 March 2024 from Rs 1,492.36 crore as of 31 March 2023.  Inventories rose to Rs 2,661.18 crore as of 31 March 2024 from Rs 2,60...

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation